Fulgent Genetics Inc
NASDAQ:FLGT

Watchlist Manager
Fulgent Genetics Inc Logo
Fulgent Genetics Inc
NASDAQ:FLGT
Watchlist
Price: 28.3 USD -0.63% Market Closed
Market Cap: 874.8m USD

During the last 3 months Fulgent Genetics Inc insiders have not bought any shares, and sold 391.3k USD worth of shares. The stock price has increased by 29% over this period (open performance analysis).

The last transaction was made on Nov 28, 2025 by Xie Jian , who sold 35.4k USD worth of FLGT shares.

Last Transactions:
Xie Jian
$-35.4k
Gao Hanlin
$-27.9k
Xie Jian
$-20.8k
Gao Hanlin
$-16.3k
Xie Jian
$-291k
Xie Jian
$-24.8k
Gao Hanlin
$-23.4k
Xie Jian
$-25.8k
Gao Hanlin
$-20.3k
Xie Jian
$-15k
Gao Hanlin
$-11.8k
Xie Jian
$-23k
Gao Hanlin
$-15.3k
Xie Jian
$-14.2k
Gao Hanlin
$-7.9k
Kim Paul
$+1.6m
Xie Jian
$-28.4k
Gao Hanlin
$-26.8k
Gao Hanlin
$-9.1k
Xie Jian
$-12.6k
Hsieh Ming
$-40.7k
Gao Hanlin
$-33k
Kim Paul
$-36.8k
Xie Jian
$-35k
Gao Hanlin
$-12.9k
Kim Paul
$-16.7k
Hsieh Ming
$-52.8k
Xie Jian
$-16.3k
Xie Jian
$-263.2k
Gao Hanlin
$-39.6k
Kim Paul
$-39.6k
Xie Jian
$-49.1k
View All Transactions

During the last 3 months Fulgent Genetics Inc insiders have not bought any shares, and sold 391.3k USD worth of shares. The stock price has increased by 29% over this period (open performance analysis).

The last transaction was made on Nov 28, 2025 by Xie Jian , who sold 35.4k USD worth of FLGT shares.

Sold
0-3
months
391.3k USD
2
3-6
months
121k USD
2
6-9
months
60.4k USD
2
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
1
1.6m USD

Fulgent Genetics Inc
Insider Trading Chart

Fulgent Genetics Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Fulgent Genetics Inc
Last Insider Transactions

Global
Insiders Monitor

Fulgent Genetics Inc
Glance View

Market Cap
873.2m USD
Industry
Health Care

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. The company is headquartered in Temple City, California and currently employs 645 full-time employees. The company went IPO on 2016-09-28. The firm develops a technology platform, which offers a test menu. The company performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels. Its test offerings also include Solid Tumor Molecular Profiling for somatic cancer testing, Rapid Whole Genome testing developed for children in neonatal intensive care units or pediatric intensive care units its Newborn Genetic Analysis panel, and a single front-line test designed to comprehensively detect ataxia-related variants. The company also offers certain research service tests, which are ordered by research institutions and other similar institutional customers.

FLGT Intrinsic Value
16.37 USD
Overvaluation 42%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top